Marvin & Palmer Associates’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-4,550
Closed -$2.4M 34
2023
Q4
$2.4M Buy
+4,550
New +$2.43M 2.67% 24
2023
Q1
Sell
-16,114
Closed -$8.54M 36
2022
Q4
$8.54M Sell
16,114
-3,436
-18% -$1.82M 4.5% 11
2022
Q3
$9.87M Sell
19,550
-923
-5% -$485K 6.06% 3
2022
Q2
$10.5M Sell
20,473
-550
-3% -$276K 5.41% 2
2022
Q1
$10.7M Buy
+21,023
New +$10.1M 4.83% 7
2019
Q1
Sell
-19,511
Closed -$4.86M 34
2018
Q4
$4.86M Buy
19,511
+3,413
+21% +$902K 4.19% 12
2018
Q3
$4.28M Buy
16,098
+1,720
+12% +$447K 3.25% 19
2018
Q2
$3.53M Hold
14,378
3.47% 20
2018
Q1
$3.08M Buy
14,378
+1,674
+13% +$382K 2.82% 22
2017
Q4
$2.8M Buy
12,704
+1,328
+12% +$281K 2.9% 22
2017
Q3
$2.23M Sell
11,376
-8,824
-44% -$1.7M 2.74% 22
2017
Q2
$3.75M Sell
20,200
-200
-1% -$35.1K 2.84% 21
2017
Q1
$3.35M Buy
20,400
+5,190
+34% +$850K 2.43% 23
2016
Q4
$2.43M Buy
+15,210
New +$2.27M 2.08% 21

Other funds holding UNH

Marvin & Palmer Associates's UNH Position: Q1 2024 in Review

Marvin & Palmer Associates sold out of UnitedHealth (UNH) in Q1 2024, closing a stake of 4,550 shares — an estimated $2.4M sold.

Marvin & Palmer Associates first reported a position in UNH in Q4 2016 and held it in 14 quarters. The position peaked at $10.7M in Q1 2022. 3,375 funds tracked by Wall St. Rank hold UNH as of Q1 2024.

  • Marvin & Palmer Associates reported no remaining UnitedHealth position as of Q1 2024 after selling out during the quarter.
  • Marvin & Palmer Associates sold 4,550 UnitedHealth shares in Q1 2024, an estimated $2.4M.
  • Marvin & Palmer Associates first reported a position in UnitedHealth in Q4 2016 and held it in 14 quarters.
  • Marvin & Palmer Associates's UnitedHealth position peaked at $10.7M in Q1 2022.
  • 3,375 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2024.

Based on Marvin & Palmer Associates's 13F filing for Q1 2024, filed 13 May 2024.